{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:22:48Z","timestamp":1793787768790,"version":"4.6.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"am","delay-in-days":273,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007826","name":"American Glaucoma Society","doi-asserted-by":"publisher","award":["EY029885"],"award-info":[{"award-number":["EY029885"]}],"id":[{"id":"10.13039\/100007826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007826","name":"American Glaucoma Society","doi-asserted-by":"publisher","award":["EY031898"],"award-info":[{"award-number":["EY031898"]}],"id":[{"id":"10.13039\/100007826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["K23 EY033831"],"award-info":[{"award-number":["K23 EY033831"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ajo.2024.06.024","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T06:49:53Z","timestamp":1720075793000},"page":"172-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Impact of Social Vulnerability Index on the Development of Severe Visual Impairment or Blindness From Glaucoma"],"prefix":"10.1016","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7198-6602","authenticated-orcid":false,"given":"SWARUP S.","family":"SWAMINATHAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FELIPE A.","family":"MEDEIROS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEVEN J.","family":"GEDDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2024.06.024_bib0001","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.06.024_bib0002","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.11.2.16","article-title":"Rates of glaucoma progression derived from linear mixed models using varied random effect distributions","volume":"11","author":"Swaminathan","year":"2022","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.786244","article-title":"Longitudinal associations of self-reported visual, hearing, and dual sensory difficulties with symptoms of depression among older adults in the United States","volume":"16","author":"Killeen","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.ajo.2024.06.024_bib0004","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/aje\/kwp453","article-title":"Untreated poor vision: a contributing factor to late-life dementia","volume":"171","author":"Rogers","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2021.09.010","article-title":"The economic burden of vision loss and blindness in the United States","volume":"129","author":"Rein","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.06.024_bib0006","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10198-019-01115-5","article-title":"Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study","volume":"21","author":"Chuvarayan","year":"2020","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.ajo.2024.06.024_bib0007","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archophthalmol.2010.86","article-title":"Economic cost of visual impairment in Japan","volume":"128","author":"Roberts","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0008","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archopht.125.4.544","article-title":"Economic impact of visual impairment and blindness in the United States","volume":"125","author":"Frick","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0009","unstructured":"Organization WH. Blindness and vision impairment, 2022. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment. Accessed February 20, 2024."},{"key":"10.1016\/j.ajo.2024.06.024_bib0010","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","author":"GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajo.2024.06.024_bib0011","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamaophthalmol.2016.1284","article-title":"Visual impairment and blindness in adults in the United States: demographic and geographic variations from 2015 to 2050","volume":"134","author":"Varma","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0012","unstructured":"Administration SS. Disability evaluation under social security: 2.00 Special Senses & Speech. Available at https:\/\/www.ssa.gov\/disability\/professionals\/bluebook\/2.00-SpecialSensesandSpeech-Adult.htm. Accessed February 20, 2024."},{"key":"10.1016\/j.ajo.2024.06.024_bib0013","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0161-6420(98)91133-2","article-title":"The probability of blindness from open-angle glaucoma","volume":"105","author":"Hattenhauer","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.06.024_bib0014","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0002-9394(02)01403-4","article-title":"Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision","volume":"133","author":"Oliver","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ogla.2019.09.002","article-title":"Lifetime risk of visual impairment resulting from glaucoma in patients initially followed up for elevated intraocular pressure","volume":"3","author":"Oskarsdottir","year":"2020","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ajo.2024.06.024_bib0016","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2021-000838","article-title":"Progression to severe visual impairment and blindness in POAG patients: pace and risk factors\u2014a cohort study using German health claims data","volume":"7","author":"Nestler","year":"2022","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136632","article-title":"Blindness and glaucoma: a multicenter data review from 7 academic eye clinics","volume":"10","author":"Rossetti","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2024.06.024_bib0018","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0161-6420(02)01974-7","article-title":"Blindness in patients with treated open-angle glaucoma","volume":"110","author":"Chen","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.06.024_bib0019","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bmj.322.7287.639","article-title":"Deprivation and late presentation of glaucoma: case-control study","volume":"322","author":"Fraser","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2024.06.024_bib0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/bjo.2008.153312","article-title":"The effect of socio-economic deprivation on severity of glaucoma at presentation","volume":"94","author":"Ng","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0021","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/eye.2008.245","article-title":"The influence of socioeconomic and clinical factors upon the presenting visual field status of patients with glaucoma","volume":"23","author":"Sukumar","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajo.2024.06.024_bib0022","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/eye.2015.157","article-title":"Measures of socioeconomic status and self-reported glaucoma in the U.K. Biobank cohort","volume":"29","author":"Shweikh","year":"2015","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.ajo.2024.06.024_bib0023","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ogla.2023.05.005","article-title":"Social vulnerability, prevalence of glaucoma, and incidence of glaucoma surgery in the California Medicare population","volume":"6","author":"Tseng","year":"2023","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ajo.2024.06.024_bib0024","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2023.02.006","article-title":"Identifying risk factors for blindness from glaucoma at first presentation to a tertiary clinic","volume":"250","author":"Shi","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajo.2023.02.008","article-title":"Five-year visual field outcomes of the HORIZON trial","volume":"251","author":"Montesano","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0026","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ajo.2021.03.019","article-title":"Rapid initial OCT RNFL thinning is predictive of faster visual field loss during extended follow-up in glaucoma","volume":"229","author":"Swaminathan","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0027","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2415-11-31","article-title":"The effect of different criteria on the number of patients blind from open-angle glaucoma","volume":"11","author":"Heijl","year":"2011","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0028","unstructured":"Registry. AfTSD. CDC\/ATDSR SVI data & documentation download. Available at https:\/\/www.atsdr.cdc.gov\/placeandhealth\/svi\/data_documentation_download.html. Accessed February 10, 2024."},{"key":"10.1016\/j.ajo.2024.06.024_bib0029","unstructured":"Centers for Disease Control and Prevention\/Agency for Toxic Substances and Disease Registry\/Geospatial Research A, and Services Program. CDC\/ATSDR Social Vulnerability Index 2018. Database. 2018. Available at https:\/\/www.atsdr.cdc.gov\/placeandhealth\/svi\/documentation\/SVI_documentation_2018.html. Accessed February 10, 2024."},{"key":"10.1016\/j.ajo.2024.06.024_bib0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajo.2024.02.022","article-title":"FA Socioeconomic disparities in glaucoma severity at initial diagnosis: a nationwide EHR cohort analysis","volume":"263","author":"Swaminathan","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0031","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ophtha.2019.09.041","article-title":"Cost-utility analysis of glaucoma medication adherence","volume":"127","author":"Newman-Casey","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.06.024_bib0032","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","article-title":"The association between medication adherence and visual field progression in the collaborative initial glaucoma treatment study","volume":"127","author":"Newman-Casey","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.06.024_bib0033","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.ophtha.2015.06.039","article-title":"Patterns of glaucoma medication adherence over four years of follow-up","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.06.024_bib0034","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/IJG.0b013e31821dac86","article-title":"Determinants of medication adherence to topical glaucoma therapy","volume":"21","author":"Dreer","year":"2012","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2024.06.024_bib0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ajo.2020.02.009","article-title":"Psychosocial predictors of glaucoma medication adherence among the support, educate, empower (SEE) personalized glaucoma coaching pilot study participants","volume":"216","author":"Salman","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.06.024_bib0036","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ogla.2023.01.008","article-title":"SL Associations between socioeconomic factors and visit adherence among patients with glaucoma in the nationwide All of Us Research Program","volume":"6","author":"Acuff","year":"2023","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ajo.2024.06.024_bib0037","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/jamaophthalmol.2017.6836","article-title":"Detection of glaucoma progression in individuals of African descent compared with those of European descent","volume":"136","author":"Gracitelli","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0038","first-page":"1115","article-title":"Longitudinal visual field variability and the ability to detect glaucoma progression in black and white individuals","volume":"106","author":"Stagg","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0039","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2022.5840","article-title":"Population prevalence of vision impairment in US adults 71 years and older: the National Health and Aging Trends Study","author":"Killeen","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0040","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2020.10.041","article-title":"Racial and socioeconomic disparities in visual impairment in the United States","volume":"128","author":"Uhr","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.06.024_bib0041","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jamaophthalmol.2022.4566","article-title":"Association of socioeconomic, demographic, and health care access disparities with severe visual impairment in the US","volume":"140","author":"Besagar","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0042","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ajo.2021.12.005","article-title":"Shared decision making in ophthalmology: a scoping review","volume":"237","author":"Bouaziz","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.06.024_bib0043","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1377\/hlthaff.2013.1397","article-title":"'Pharmacy deserts' are prevalent in Chicago's predominantly minority communities, raising medication access concerns","volume":"33","author":"Qato","year":"2014","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.ajo.2024.06.024_bib0044","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2146\/ajhp150872","article-title":"Evaluation of racial and socioeconomic disparities in medication pricing and pharmacy access and services","volume":"74","author":"Chisholm-Burns","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ajo.2024.06.024_bib0045","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s40615-020-00904-6","article-title":"Social determinants of pharmacy deserts in Los Angeles county","volume":"8","author":"Wisseh","year":"2021","journal-title":"J Racial Ethn Health Disparities"},{"key":"10.1016\/j.ajo.2024.06.024_bib0046","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/iovs.61.13.8","article-title":"The effect of age on increasing susceptibility to retinal nerve fiber layer loss in glaucoma","volume":"61","author":"Jammal","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2024.06.024_bib0047","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.ophtha.2019.07.023","article-title":"Corneal biomechanics and visual field progression in eyes with seemingly well-controlled intraocular pressure","volume":"126","author":"Susanna","year":"2019","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424002885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424002885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T05:44:10Z","timestamp":1728971050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939424002885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":47,"alternative-id":["S0002939424002885"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.06.024","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Social Vulnerability Index on the Development of Severe Visual Impairment or Blindness From Glaucoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}